Xi'an International Medical Investment Company Limited commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on May 20, 2024.

Xi'an International Medical Investment Company Limited (SZSE:000516) commences share repurchases on May 27, 2024, under the program mandated by the shareholders in the Annual General Meeting held on May 20, 2024. As per the mandate, the company is authorized to repurchase to repurchase CNY 150 million worth of its common shares. The shares will be purchased at a price not exceeding CNY 9.16 per share.

The purpose of the program is to reduce company's share capital. The repurchased shares will be cancelled. The program will be funded from company's own funds.

The program will be valid for 12 months.